Visual evoked potentials follow-up in idiopathic intracranial hypertension

References

1. ↵
   1. McCluskey G,
   2. Mulholland DA,
   3. McCarron P,
   4. McCarron MO

   (2015) Idiopathic Intracranial Hypertension in the Northwest of Northern Ireland:Epidemiology and Clinical Management. Neuroepidemiology 45, 34–39.
2. ↵
   1. Akçakaya NH,
   2. Akçakaya MO,
   3. Sencer A,
   4. Yapıcı Z

   (2017) Idiopathic Intracranial Hypertension:Diagnosis and Therapeutic Approach. Turkish Journal of Neurology 23, 43–50.
3. ↵
   1. Kilgore KP,
   2. Lee MS,
   3. Leavitt JA,
   4. Mokri B,
   5. Hodge DO,
   6. Frank RD,
   7. et al.

   (2017) Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity. Ophthalmology 124, 697–700.
4. ↵
   1. Portelli M,
   2. Papageorgiou PN

   (2017) An update on idiopathic intracranial hypertension. Acta Neurochir (Wien) 159, 491–499.
5. ↵
   1. Doubi AO,
   2. Aljomah DS,
   3. Alhargan AO,
   4. Alfawwaz FS

   (2018) The Effect of lumbar drains on spontaneous cerebrospinal fluid leak repair. Neurosciences (Riyadh) 23, 281–285.
6. ↵
   1. Wall M

   (2014) The importance of visual field testing in idiopathic intracranial hypertension. Continuum (Minneap Minn) 20, 1067–1074.
7. ↵
   1. Willenborg KD,
   2. Nacimiento W

   (2015) [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension]. Ophthalmologe 112, 814–820, German.
8. ↵
   1. Markey KA,
   2. Mollan SP,
   3. Jensen RH,
   4. Sinclair AJ

   (2016) Understanding idiopathic intracranial hypertension:mechanisms, management, and future directions. Lancet Neurol 15, 78–91.
9. ↵
   1. Razek AAKA,
   2. Batouty N,
   3. Fathy W,
   4. Bassiouny R

   (2018) Diffusion tensor imaging of the optic disc in idiopathic intracranial hypertension. Neuroradiology 60, 1159–1166.
10. ↵
    1. Hales CM,
    2. Fryar CD,
    3. Carroll MD,
    4. Freedman DS,
    5. Ogden CL

    (2018) Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age 2007-2008 to 2015-2016. JAMA 319, 1723–1725.
11. ↵
    1. Czosnyka Z,
    2. Czosnyka M

    (2017) Long-term monitoring of intracranial pressure in normal pressure hydrocephalus and other CSF disorders. Acta Neurochir (Wien) 159, 1979–1980.
12. ↵
    1. Huang-Link Y,
    2. Eleftheriou A,
    3. Yang G,
    4. Johansson JM,
    5. Apostolou A,
    6. Link H,
    7. et al.

    (2019) Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema. Eur J Neurol 26, 808–e57.
13. ↵
    1. Takkar A,
    2. Goyal MK,
    3. Bansal R,
    4. Lal V

    (2018) Clinical and Neuro-ophthalmologic Predictors of Visual Outcome in Idiopathic Intracranial Hypertension. Neuroophthalmology 42, 201–208.
14. ↵
    1. Al Abdulsalam HK,
    2. Ajlan AM

    (2017) Idiopathic intracranial hypertension in males. Neurosciences (Riyadh) 22, 220–223.
15. ↵
    1. Bulut MN,
    2. Oral AY,
    3. Bulut K

    (2015) Pattern VEP (Desen Görsel UyarılmışPotansiyel) Normal Değerlerimiz. J Kartal TR 26, 109–114.
16. ↵
    1. Ilik F,
    2. Pazarli AC,
    3. Kayhan F,
    4. Karamanli H,
    5. Ozlece HK

    (2016) Electrophysiological assessment in patients with long term hypoxia. Neurosciences (Riyadh) 21, 26–29.
17. ↵
    1. Hamzeii-Moghadam A,
    2. Seifaddini R,
    3. Hamzei E,
    4. Khanjani N

    (2014) Comparison of Visual Evoked Potentials and Perimetry Changes in Patients with Idiopathic Intracranial Hypertension. Zahedan Journal of Research in Medical Sciences 16, 24–27.
18. ↵
    1. Ardissino M,
    2. Moussa O,
    3. Tang A,
    4. Muttoni E,
    5. Ziprin P,
    6. Purkayastha S

    (2019) Idiopathic intracranial hypertension in the British population with obesity. Acta Neurochir (Wien) 161, 239–246.
19. ↵
    1. Zafar A,
    2. Khatri IA

    (2018) An overview of complications affecting the Central Nervous System following bariatric surgery. Neurosciences (Riyadh) 23, 4–12.
20. ↵
    1. Arslan D,
    2. Arıkanoğlu A,
    3. Akıl E

    (2017) Clinical and Demographic Features of Pseudotumor Cerebri Syndrome Diagnosed in a University Hospital. Turkish Journal of Neurology 23, 60–63.
21. ↵
    1. Wall M,
    2. Kupersmith MJ,
    3. Kieburtz KD,
    4. Corbett JJ,
    5. Feldon SE,
    6. Friedman DI,
    7. et al.

    (2014) The idiopathic intracranial hypertension treatment trial:clinical profile at baseline. JAMA Neurol 71, 693–701.
22. ↵
    1. Hainline C,
    2. Rucker JC,
    3. Balcer LJ

    (2016) Current concepts in pseudotumor cerebri. Curr Opin Neurol 29, 84–93.
23. ↵
    1. Almarzouqi SJ,
    2. Morgan ML,
    3. Lee AG

    (2015) Idiopathic intracranial hypertension in the Middle East:A growing concern. Saudi J Ophthalmol 29, 26–31.
24. ↵
    1. Keskin AO,
    2. Idiman F,
    3. Kaya D,
    4. Bircan B

    (2017) Idiopathic Intracranial Hypertension:Etiological factors, Clinical Features, and Prognosis. Headache 1, 4.
25. ↵
    1. Bidot S,
    2. Bruce BB,
    3. Saindane AM,
    4. Newman NJ,
    5. Biousse V

    (2015) Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol 35, 31–36.
26. ↵
    1. Wall M,
    2. Kupersmith MJ,
    3. Kieburtz KD,
    4. Corbett JJ,
    5. Feldon SE,
    6. Friedman DI,
    7. et al.

    (2014) The idiopathic intracranial hypertension treatment trial:clinical profile at baseline. JAMA Neurology 71, 693–701.
27. ↵
    1. Smith SV,
    2. Friedman DI

    (2017) The Idiopathic Intracranial Hypertension Treatment Trial:A Review of the Outcomes. Headache 57, 1303–1310.
28. ↵
    1. Gafoor VA,
    2. Smita B,
    3. Jose J

    (2017) Long-term Response of Cerebrospinal Fluid Pressure in Patients with Idiopathic Intracranial Hypertension - A Prospective Observational Study. Ann Indian Acad Neurol 20, 220–224.
29. ↵
    1. El Habashy HR El,
    2. Gohary AM,
    3. Azmy RM,
    4. Hegazy MI,
    5. Elsanabary ZS,
    6. Tawfeek AA

    (2014) Multifocal Visual Evoked Potential in Idiopathic Intracranial Hypertension. Egyptian Journal of Neurology, Psychiatry & Neurosurgery 51, 477–482.